These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18432745)

  • 1. Measurement of MHC/peptide interactions by gel filtration.
    Sidney J; Southwood S; Oseroff C; del Guercio MF; Sette A; Grey HM
    Curr Protoc Immunol; 2001 May; Chapter 18():Unit 18.3. PubMed ID: 18432745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of peptide-MHC interactions in solution using the spin column filtration assay.
    Buus S; Lise Lauemøller S; Stryhn A; Østergaard Pedersen L
    Curr Protoc Immunol; 2001 May; Chapter 18():Unit 18.4. PubMed ID: 18432746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.
    Sidney J; Southwood S; Moore C; Oseroff C; Pinilla C; Grey HM; Sette A
    Curr Protoc Immunol; 2013 Feb; Chapter 18():Unit 18.3.. PubMed ID: 23392640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction.
    Sylvester-Hvid C; Kristensen N; Blicher T; Ferré H; Lauemøller SL; Wolf XA; Lamberth K; Nissen MH; Pedersen LØ; Buus S
    Tissue Antigens; 2002 Apr; 59(4):251-8. PubMed ID: 12135423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of radioiodinated influenza virus peptides to class I MHC molecules and to other cellular proteins as analyzed by gel filtration and photoaffinity labeling.
    Reyes VE; Lu S; Humphreys RE
    Mol Immunol; 1991; 28(4-5):341-8. PubMed ID: 2062316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic peptide binding to MHC class II molecules at increased peptide concentrations.
    Nag B; Mukku PV; Arimilli S; Phan D; Deshpande SV; Winkelhake JL
    Mol Immunol; 1994 Oct; 31(15):1161-8. PubMed ID: 7523870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.
    Torabi-Pour N; Nouri AM; Perrett D; Oliver RT
    Biomed Chromatogr; 2001 Feb; 15(1):18-24. PubMed ID: 11180296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition-based cellular peptide binding assay for HLA class I.
    Kessler JH; Benckhuijsen WE; Mutis T; Melief CJ; van der Burg SH; Drijfhout JW
    Curr Protoc Immunol; 2004 Sep; Chapter 18():Unit 18.12. PubMed ID: 18432926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct peptide-regulatable interactions between MHC class I molecules and tapasin.
    Rizvi SM; Raghavan M
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18220-5. PubMed ID: 17116884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.
    Olsen AC; Pedersen LO; Hansen AS; Nissen MH; Olsen M; Hansen PR; Holm A; Buus S
    Eur J Immunol; 1994 Feb; 24(2):385-92. PubMed ID: 8299688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assay for simultaneous multiple determinations of peptide binding to MHC class II molecules.
    Manfredi AA; Yuen MH; Raftery MA; Conti-Tronconi BM
    Anal Biochem; 1993 Jun; 211(2):267-73. PubMed ID: 8317702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide bond engineering to trap peptides in the MHC class I binding groove.
    Truscott SM; Lybarger L; Martinko JM; Mitaksov VE; Kranz DM; Connolly JM; Fremont DH; Hansen TH
    J Immunol; 2007 May; 178(10):6280-9. PubMed ID: 17475856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.
    Ishioka GY; Adorini L; Guery JC; Gaeta FC; LaFond R; Alexander J; Powell MF; Sette A; Grey HM
    J Immunol; 1994 May; 152(9):4310-9. PubMed ID: 8157954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand Design for Specific MHC Class I Molecules on the Cell Surface.
    Sun X; Tokunaga R; Nagai Y; Miyahara R; Kishimura A; Kawakami S; Katayama Y; Mori T
    Biochemistry; 2020 Dec; 59(49):4646-4653. PubMed ID: 33252220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN; Flower DR
    Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct binding of influenza peptides to class I HLA molecules.
    Chen BP; Parham P
    Nature; 1989 Feb; 337(6209):743-5. PubMed ID: 2918908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.